While the original model for transcellular propagation of soluble tau aggregates is centered on neurons, tau oligomers also accumulate in the brain microvasculature, both in neurodegenerative diseases such as AD and progressive supranuclear palsy (PSP), as wells as in mouse models of AD18. This evidence concerns the gene MAPT and Alzheimer disease 18.